-
1
-
-
0034651580
-
Pathogenesis, natural history, treatment and prevention of hepatitis C
-
Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 2000; 132:296-305.
-
(2000)
Ann Intern Med
, vol.132
, pp. 296-305
-
-
Liang, T.J.1
Rehermann, B.2
Seeff, L.B.3
Hoofnagle, J.H.4
-
2
-
-
33644547392
-
Antiviral therapy for chronic hepatitis C: Past, present, and future
-
DOI 10.1007/s00535-005-1740-7
-
Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: past, present, and future. J Gastroenterol 2006; 41:17-27. (Pubitemid 43299871)
-
(2006)
Journal of Gastroenterology
, vol.41
, Issue.1
, pp. 17-27
-
-
Hayashi, N.1
Takehara, T.2
-
3
-
-
0037974623
-
Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication
-
DOI 10.1128/AAC.47.7.2293-2298.2003
-
Buckwold VE, Wei J, Wenzel-Mathers M, Russell J. Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication. Antimicrob Agents Chemother 2003; 47:2293-2298. (Pubitemid 36753585)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.7
, pp. 2293-2298
-
-
Buckwold, V.E.1
Wei, J.2
Wenzel-Mathers, M.3
Russell, J.4
-
4
-
-
0034896124
-
High-level expression of hepatitis C virus (HCV) structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype
-
DOI 10.1016/S0166-0934(01)00339-1, PII S0166093401003391
-
Nam JH, Bukh J, Purcell RH, Emerson SU. High-level expression of hepatitis C virus (HCV) structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype. J Virol Methods 2001; 97:113-123. (Pubitemid 32718746)
-
(2001)
Journal of Virological Methods
, vol.97
, Issue.1-2
, pp. 113-123
-
-
Nam, J.-H.1
Bukh, J.2
Purcell, R.H.3
Emerson, S.U.4
-
5
-
-
0036753024
-
The combination of interferon α-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: Implications for hepatitis C virus (HCV) therapy
-
DOI 10.1016/S0166-3542(02)00075-X, PII S016635420200075X
-
Ouzounov S, Mehta A, Dwek RA, Block TM, Jordan R. The combination of interferon α-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral Res 2002; 55:425-435. (Pubitemid 35223098)
-
(2002)
Antiviral Research
, vol.55
, Issue.3
, pp. 425-435
-
-
Ouzounov, S.1
Mehta, A.2
Dwek, R.A.3
Block, T.M.4
Jordan, R.5
-
6
-
-
0345188811
-
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
-
DOI 10.1126/science.285.5424.110
-
Lohmann V, Körner F, Koch JO, Herian U, Thielmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNA in a hepatoma cell line. Science 1999; 285:110-113. (Pubitemid 29307577)
-
(1999)
Science
, vol.285
, Issue.5424
, pp. 110-113
-
-
Lohmann, V.1
Korner, F.2
Koch, J.-O.3
Herian, U.4
Theilmann, L.5
Bartenschlager, R.6
-
7
-
-
85047692907
-
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA
-
DOI 10.1016/S0042-6822(03)00152-I
-
Zhou S, Liu R, Baroudy BM, Malcom BA, Reyes GR. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. Virology 2003; 310:333-342. (Pubitemid 37492916)
-
(2003)
Virology
, vol.310
, Issue.2
, pp. 333-342
-
-
Zhou, S.1
Liu, R.2
Baroudy, B.M.3
Malcolm, B.A.4
Reyes, G.R.5
-
8
-
-
21544440397
-
Robust hepatitis C virus infection in vitro
-
DOI 10.1073/pnas.0503596102
-
Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 2005; 102:9294-9299. (Pubitemid 40923557)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.26
, pp. 9294-9299
-
-
Zhong, J.1
Gastaminza, P.2
Cheng, G.3
Kapadia, S.4
Kato, T.5
Burton, D.R.6
Wieland, S.F.7
Uprichard, S.L.8
Wakita, T.9
Chisari, F.V.10
-
9
-
-
22544470874
-
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
-
DOI 10.1038/nm1268
-
Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791-796. (Pubitemid 41021213)
-
(2005)
Nature Medicine
, vol.11
, Issue.7
, pp. 791-796
-
-
Wakita, T.1
Pietschmann, T.2
Kato, T.3
Date, T.4
Miyamoto, M.5
Zhao, Z.6
Murthy, K.7
Habermann, A.8
Krausslich, H.-G.9
Mizokami, M.10
Bartenschlager, R.11
Liang, T.J.12
-
10
-
-
23044437222
-
Virology: Complete replication of hepatitis C virus in cell culture
-
DOI 10.1126/science.1114016
-
Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623-626. (Pubitemid 41033648)
-
(2005)
Science
, vol.309
, Issue.5734
, pp. 623-626
-
-
Lindenbach, B.D.1
Evans, M.J.2
Syder, A.J.3
Wolk, B.4
Tellinghuisen, T.L.5
Liu, C.C.6
Maruyama, T.7
Hynes, R.O.8
Burton, D.R.9
McKeating, J.A.10
Rice, C.M.11
-
11
-
-
17144377915
-
Colorimetric lactate dehydrogenase (LDH) assay for evaluation of antiviral activity against bovine viral diarrhoea virus (BVDV) in vitro
-
Baba C, Yanagida K, Kanzaki T, Baba M. Colorimetric lactate dehydrogenase (LDH) assay for evaluation of antiviral activity against bovine viral diarrhea virus (BVDV) in vitro. Antivir Chem Chemother 2005; 16:33-39. (Pubitemid 40754327)
-
(2005)
Antiviral Chemistry and Chemotherapy
, vol.16
, Issue.1
, pp. 33-39
-
-
Baba, C.1
Yanagida, K.2
Kanzaki, T.3
Baba, M.4
-
12
-
-
65749097671
-
Discovery of diphenylmethane analogs as anti-bovine diarrhea viral agents
-
Hosoda S, Aoyama H, Goto Y, et al. Discovery of diphenylmethane analogs as anti-bovine diarrhea viral agents. Bioorg Med Chem Lett 2009; 19:3157-3161.
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 3157-3161
-
-
Hosoda, S.1
Aoyama, H.2
Goto, Y.3
-
13
-
-
41649116221
-
γ-Carboline derivatives with anti-bovine viral diarrhea virus (BVDV) activity
-
DOI 10.1016/j.bmc.2008.01.052, PII S0968089608000722
-
Sako K, Aoyama H, Sato S, Hashimoto Y, Baba M. γ-Carboline derivatives with anti-bovine viral diarrhea virus (BVDV) activity. Bioorg Med Chem 2008; 16:3780-3790. (Pubitemid 351484034)
-
(2008)
Bioorganic and Medicinal Chemistry
, vol.16
, Issue.7
, pp. 3780-3790
-
-
Sako, K.1
Aoyama, H.2
Sato, S.3
Hashimoto, Y.4
Baba, M.5
-
14
-
-
0141456064
-
Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents
-
DOI 10.1016/S0166-3542(03)00174-8
-
Buckwold VE, Beer BE, Donis RO. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res 2003; 60:1-15. (Pubitemid 37153391)
-
(2003)
Antiviral Research
, vol.60
, Issue.1
, pp. 1-15
-
-
Buckwold, V.E.1
Beer, B.E.2
Donis, R.O.3
-
15
-
-
33645966527
-
A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase
-
Paeshuyse J, Leyssen P, Mabery E, et al. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. J Virol 2006; 80:149-160.
-
(2006)
J Virol
, vol.80
, pp. 149-160
-
-
Paeshuyse, J.1
Leyssen, P.2
Mabery, E.3
|